MUC2 and keratoconus: Likewise, the administration of KC and DRC appeared to reduce Enterobacteriaceae, consequently maintaining anti-inflammatory and mucosal barrier activities via reduced TNF-α expression and release, and enhanced TJ protein and MUC-2 expression.